Related Industry Reports:
Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors.
Bioorganic & medicinal chemistry letters 2010 Jul 8; In press
Belanger D DB, Curran P PJ, Hruza A, Voigt J, Meng Z, Mandal A AK, Siddiqui M MA, Basso A AD, Gray K
Department of Chemistry, Merck Research Laboratories, 320 Bent Street, Cambridge, MA 02141, United States.
The synthesis and structure-activity relationships (SAR) of novel, potent imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors are described. The X-ray crystal structure of imidazo[1,2-a]pyrazine Aurora inhibitor 1j is disclosed. Compound 10i was identified as lead compound with a promising overall profile.
Keywords: Aurora kinase
